The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s viscosupplementation market report forecasts the viscosupplementation market size to grow to $5.36 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

Learn More On The Viscosupplementation Market Report 2023 – https://www.thebusinessresearchcompany.com/report/viscosupplementation-global-market-report

Viscosupplementation Market Size Forecast
The global viscosupplementation market is expected to grow from $3.37 billion in 2022 to $3.73 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global viscosupplementation market size is expected to reach $5.36 billion in 2027 at a CAGR of 9.5%.

North America held the largest viscosupplementation market share.

Key Viscosupplementation Market Driver ­– Rise In The Prevalence Of Osteoarthritis
According to the Centres for Disease Control and Prevention (CDC), a US-based public health care organisation, 78.4 million persons aged 18 and older in the United States are expected to have arthritis by 2040. As a result, the rising prevalence of osteoarthritis is propelling the viscosupplementation market ahead.

Request for A Sample Of The Global Viscosupplementation Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9836&type=smp

Key Viscosupplementation Market Trend – Technological Advancement
Companies in the viscosupplementation industry are embracing new technologies in order to maintain their market position. Seikagaku Corporation, a Japanese pharmaceutical company, introduced HyLink®, a revolutionary viscosupplement provided through intra-articular single injection, to treat knee osteoarthritis, in August 2021. Cross-linking technology is being implemented into HyLink®. This cross-linking method is utilised to create the cross-linked hyaluronate hydrogel, which remains in the joint cavity for a long period and is the key ingredient in HyLink®, making it a long-lasting treatment.

Viscosupplementation Market Segment
1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
2) By Source: Avian Origin, Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Viscosupplementation Market Major Players and Strategies
Major players in the viscosupplementation market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Sanofi S.A., Zimmer Biomet, Avanos Medical Inc., Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Teva Pharmaceutical Industries Ltd., Merck KGaA, Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., and Fidia Farmaceutici S.P.A.

Avanos Medical Inc., a medical technology business based in the United States, paid $160 million for OrthogenRx Inc. in December 2021. By providing therapy choices for knee osteoarthritis patients, this acquisition enlarged, diversified, and enriched Avanos Medical Inc.’s chronic pain product range. The acquisition sought to improve partnerships with healthcare practitioners worldwide for the treatment of musculoskeletal pain. OrthogenRx Inc. is a medical device firm established in the United States that specialises in viscosupplementation therapies for the treatment of knee osteoarthritis.

The Viscosupplementation Global Market Report 2023 covers regional data on viscosupplementation market size, viscosupplementation market trends and drivers, opportunities, strategies, and viscosupplementation market competitor analysis. The countries covered in the viscosupplementation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Viscosupplementation is a procedure in which hyaluronic acid, a gel-like fluid, is injected directly into the joint. Hyaluronic acid is naturally found in synovial fluid around joints, which helps to reduce friction while moving.

View More Reports Related To The Viscosupplementation Market –
Orthobiologics Devices And Equipment Global Market Report 2023
Orthopedic Biomaterials Global Market Report 2023
Botanical Supplements Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: